RBC copper measures the concentration of copper inside red blood cells. Because red blood cells reflect copper status over their lifespan of approximately 120 days, RBC copper provides a longer-term indicator of copper status than plasma copper, which is influenced by acute inflammation and caeruloplasmin levels.
Copper is incorporated into erythrocytes during red cell production in the bone marrow. RBC copper better reflects the copper available to tissues during the preceding 3-4 months, making it a more stable and reliable marker for detecting chronic copper deficiency or the effects of sustained copper excess.
FAQs
Why is RBC copper preferred over plasma copper for long-term assessment?
Plasma copper reflects current transport capacity and is elevated by inflammation regardless of true copper status. RBC copper reflects the copper available to tissues during the preceding 3-4 months of red cell lifespan, making it a more stable long-term marker.
What symptoms does copper deficiency cause?
Copper deficiency causes anaemia (due to impaired iron metabolism), neutropenia (reduced white cell production), and neurological complications including myelopathy (spinal cord damage) with sensory disturbance, ataxia, and weakness. Neurological copper deficiency is often missed because serum B12 and B12 deficiency are investigated first.
Can zinc supplements cause low RBC copper?
Yes. High-dose zinc supplementation induces metallothionein in intestinal cells that preferentially binds copper, blocking its absorption. Chronic high-dose zinc use can deplete RBC and tissue copper over months.
Is RBC copper routinely available?
RBC copper is available through specialist trace element laboratories but is not part of standard blood panels. It is ordered specifically when long-term copper status assessment is needed.
